Accordingly, co-injection of TGF-β-primed CD4+CD25+ cells but not control (CD4con) cells significantly prolonged the survival of lupus mice in a manner consistent with a previous report (Figure 2F) [9]. This evidence concerns the gene TGFB1 and systemic lupus erythematosus.